<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01219842</url>
  </required_header>
  <id_info>
    <org_study_id>Sahlgrenska Academy</org_study_id>
    <nct_id>NCT01219842</nct_id>
  </id_info>
  <brief_title>Invasive Revascularization or Not in Intermittent Claudication</brief_title>
  <acronym>IRONIC</acronym>
  <official_title>Invasive Revascularization or Not in Intermittent Claudication</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sahlgrenska University Hospital, Sweden</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Göteborg University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Sahlgrenska University Hospital, Sweden</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Peripheral arterial disease (PAD) often causes exertion pain in the legs, intermittent
      claudication (CI) affecting&gt; 10% of individuals&gt; 65 years. A recent Swedish Health Technology
      Assessment Report identified only limited evidence for the effectiveness of invasive
      treatment for IC in patients already on exercise training. The prognosis for the extremity is
      usually benign and treatment therefore aims at improving quality of life. Invasive treatment
      can also cause serious complications. Coronary artery disease is common in IC patients
      increasing the risk with invasive treatment. In spite of these uncertain merits and potential
      risks, invasive procedures for IC are increasing and 37% of all invasive procedures for PAD
      in Sweden are performed for IC. The aim of this study is to evaluate the additional effects
      of modern invasive treatment in patients with intermittent claudication receiving modern best
      medical treatment (BMT). The primary hypothesis in the study is that invasive treatment in
      addition to BMT improves health related quality of life and walking performance compared to
      BMT only.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>March 2010</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Actual">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Health Related Quality of Life (HRQOL)</measure>
    <time_frame>24 months with intermistic analysis at 12 months</time_frame>
    <description>Assessed with the patient-reported instruments SF-36, EQ5D and VASCUQOL</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Walking performance on treadmill test</measure>
    <time_frame>24 months with interimistic analysis at 12 months</time_frame>
    <description>Graded treadmill test with progressively increasing speed and inclination.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health Related Quality of Life (HRQOL)</measure>
    <time_frame>60 months</time_frame>
    <description>Assessed with the patient-reported instruments SF-36, EQ5D and VASCUQOL</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Walking performance on treadmill test</measure>
    <time_frame>60 months</time_frame>
    <description>Graded treadmill test with progressively increasing speed and inclination.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>six-minutes walk test</measure>
    <time_frame>60 months</time_frame>
    <description>Corridor-based walk test during six minutes walk</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">159</enrollment>
  <condition>Intermittent Claudication</condition>
  <arm_group>
    <arm_group_label>INVASIVE (INV) group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Modern endovascular and/or open revascularization according to the recommendations in the TASC II document.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>NON-INVASIVE (NON) group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients receiving only best medical treatment (BMT).</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>INVASIVE (INV) treatment</intervention_name>
    <description>Modern endovascular and/or open revascularisation according to the TASC II recommendations.</description>
    <arm_group_label>INVASIVE (INV) group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Best medical treatment (BMT)</intervention_name>
    <description>Antiplatelet therapy, cilostazol and non-supervised exercise training. Smoking cessation support. Lipid-lowering therapy, diabetes and hypertension treated according to current national guidelines.</description>
    <arm_group_label>INVASIVE (INV) group</arm_group_label>
    <arm_group_label>NON-INVASIVE (NON) group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient with intermittent claudication (typical symptoms and ABI &lt;0.9) seeking
             treatment

          -  Significant aortoiliac- and/or femoropopliteal lesion.

          -  Age 30-80 years

        Exclusion Criteria:

          -  Invasive treatment contraindicated because of severe intercurrent disease.

          -  Two or more failed vascular reconstructions in the same leg.

          -  Employees unable to work because of intermittent claudication.

          -  Need for open reconstruction below the tibioperoneal trunc.

          -  Thromboembolic etiology (popliteal artery aneurysm; cardiac emboli)

          -  Other disease severely affecting walking performance.

          -  Body weight &gt; 120 kilograms.

          -  Age &lt;30 or &gt; 80 years.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joakim Nordanstig, M D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sahlgrenska Academy, Institute of Medicine, Department of Molecular and Clinical Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lennart Jivegård, M D, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Sahlgrenska Academy, Institute of Medicine, department of Molecular and Clinical Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Klas Österberg, M D, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Sahlgrenska Academy, Institute of Medicine, Department of Molecular and Clinical Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Johan Millinger, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Sahlgrenska Academy, Institute of Medicine, Department of Molecular and Clinical Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sahlgrenska University Hospital</name>
      <address>
        <city>Gothenburg</city>
        <zip>413 45</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 12, 2010</study_first_submitted>
  <study_first_submitted_qc>October 12, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 13, 2010</study_first_posted>
  <last_update_submitted>October 12, 2016</last_update_submitted>
  <last_update_submitted_qc>October 12, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 13, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sahlgrenska University Hospital, Sweden</investigator_affiliation>
    <investigator_full_name>Joakim Nordanstig</investigator_full_name>
    <investigator_title>vascular surgeon, PhD student</investigator_title>
  </responsible_party>
  <keyword>Intermittent claudication</keyword>
  <keyword>Health Related Quality of Life</keyword>
  <keyword>Walking performance</keyword>
  <keyword>Daily walking capacity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Intermittent Claudication</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

